ARLINGTON, Virginia, August 20, 2026, 06:05 EDT — U.S. cash markets are set to begin trading at 09:30 EDT.
- Boeing stock finished Wednesday at $222.20, representing a 4.7% decline from August 11.
- A fresh whistleblower documentary was released while Boeing ramps up aircraft production.
- In July, deliveries lagged Airbus by 14 aircraft, making execution the key measure for valuation.
The Boeing Company NYSE:BA fell 4.7% over eight sessions, with shares ending Wednesday at $222.20, marking a 0.4% decline for the day. The drop came as the company faced increased safety investigations and reported a softer delivery figure for July.
A new spark is the release of Freefall: A Reckoning for Boeing. Streaming started Wednesday for Rory Kennedy’s documentary, which examines previous whistleblower accusations and Boeing’s approach to safety. Boeing maintains that several claims are incorrect or have already been resolved.
For investors, the film is relevant through its impact on oversight and output. Boeing requires increased and consistent deliveries to turn its record backlog into cash flow. Additional regulatory hurdles would hinder that progress.
| Date | BA close | Change since Aug. 11 |
|---|---|---|
| Aug. 11, 2026 | $233.24 | — |
| Aug. 18, 2026 | $223.06 | -4.4% |
| Aug. 19, 2026 | $222.20 | -4.7% |
Shares have declined by $11.04 each since August 11, resulting in a loss of approximately $8.7 billion in market capitalization based on around 790 million outstanding shares. The estimation relies on published closing prices and the latest share total.
Boeing delivered 53 commercial jets in July, an increase of five compared to the same month last year. However, this figure marked a 17% drop from June, when 64 jets were delivered, and continued to lag behind Airbus SE EPA:AIR, which reported 67 deliveries.
| Delivery measure | Aircraft | Investor read-through |
|---|---|---|
| Boeing, July | 53 | 17% lower than June |
| Airbus, July | 67 | Surpassed Boeing by 14 |
| Boeing, Jan.–July | 367 | 737 MAX made up 279 deliveries |
| Boeing Q2 | 171 | 14% higher compared to Q2 2025 |
The difference is clear. In July, Boeing delivered 20.9% less aircraft compared to Airbus. Of Boeing’s deliveries, 39 were MAX jets, accounting for 73.6% of its total for the month, highlighting the recovery’s focus on a single program.
Progress has been made on regulatory fronts. The Federal Aviation Administration granted certification to the 737 MAX 7 on August 3. The agency also reinstated Boeing’s authority to issue airworthiness certificates for all MAX and 787 models, following an eight-month quality review. FAA inspectors will continue to oversee operations on site.
| Q2 2026 metric | Result | Year-on-year / context |
|---|---|---|
| Revenue | $24.56 billion | Increase of 8% |
| Free cash flow | $631 million | Turned positive from -$200 million |
| Total backlog | $715 billion | All-time high |
| Cash and investments | $20.0 billion | Less than the $45.9 billion in debt |
Chief Executive Kelly Ortberg stated that operations had improved in stability and that significant certification programs were progressing according to schedule. He added there was more to be done during the second half. Cash figures back up both statements.
| Firm | Recommendation | Target | Upside to $222.20 |
|---|---|---|---|
| Argus | Buy | $265 | 19.3% |
| Tigress Financial | Buy | $305 | 37.3% |
| BNP Paribas Exane | Outperform | $300 | 35.0% |
| JPMorgan | Overweight | $290 | 30.5% |
| RBC Capital Markets | Outperform | $265 | 19.3% |
Analysts maintain a positive outlook. The five published targets suggest an upside range of 19% to 37%. This confidence is based on production increases translating to deliveries and cash flow, provided there are no further quality issues.
Risks: New whistleblower testimony, a negative court decision, or stricter FAA action may push back production. Financial reserves have limits. Debt was $25.9 billion greater than cash and investments at the close of the quarter.
August deliveries mark the next important test. If deliveries rebound above July’s total of 53, it would bolster the outlook for Boeing’s recovery. A miss would mean safety oversight and production execution remain closely linked.
Related articles: NYSE:BA
Boeing: output must outrun scrutiny
Price path: gains faded after early-August highs
Delivery engine
Analyst targets still price in recovery
| Firm | View | Target | Upside |
|---|---|---|---|
| Argus | Buy | $265 | 19.3% |
| Tigress | Buy | $305 | 37.3% |
| BNP Paribas | Outperform | $300 | 35.0% |
| JPMorgan | Overweight | $290 | 30.5% |
| RBC | Outperform | $265 | 19.3% |
